Abstract
Cardiovascular disease is the largest cause of death in Western societies and it primarily results from atherosclerosis of large and medium-sized vessels. Atherosclerosis leads to myocardial infarction, when it occurs in the coronary arteries, or stroke, when it occurs in the cerebral arteries. Pathological processes involved in macrovascular disease include the accumulation of lipids which are retained by extracellular matrix (ECM) molecules, especially by the chondroitin sulfate/dermatan sulfate (CS/DS) proteoglycans (CS/DSPGs), such as versican, biglycan and decorin. The sulfation pattern of CS is a key player in protein interactions causing atherosclerosis. Several studies have shown that lipoproteins bind CSPGs via their glycosaminoglycan chains. Galactosaminoglycans, such as CS and DS, bind low density lipoproteins (LDL), affecting the role of these molecules in the arterial wall. In this article, the role of CS and versican in atherosclerosis and hyaluronan in atherogenesis as well as the up to date known mechanisms that provoke this pathological condition are presented and discussed.
Keywords: Atherosclerosis, glycosaminoglycans, chondroitin sulfate, versican, lipoproteins, cellular mechanisms, chondroitin sulfate/dermatan sulfate, CS/DS, proteoglycans, CS/DSPGs, vascular cell adhesion molecule-1, VCAM-1, GAGs, Galactosaminoglycans, GalAGs, Dglucuronic acid, N-acetyl-D-galactosamine, Hyaluronan, Hyaluronan-Mediated Motility, RHAMM, Lymphatic Vessel Endothelial Receptor 1, LYVE-1, Hyaluronan Receptor for Endocytosis, HARE, Toll Like Receptors 4, TLR4, human aortic smooth muscle cells, AoSMCs, ADAMTS, TFPI-1, Tissue Factor Pathway Inhibitor-1
Current Medicinal Chemistry
Title: Glycosaminoglycans as Key Molecules in Atherosclerosis: The Role of Versican and Hyaluronan
Volume: 17 Issue: 33
Author(s): D. E. Karangelis, I. Kanakis, A. P. Asimakopoulou, E. Karousou, A. Passi, A. D. Theocharis, F. Triposkiadi, N. B. Tsilimingas and Nikos K. Karamanos
Affiliation:
Keywords: Atherosclerosis, glycosaminoglycans, chondroitin sulfate, versican, lipoproteins, cellular mechanisms, chondroitin sulfate/dermatan sulfate, CS/DS, proteoglycans, CS/DSPGs, vascular cell adhesion molecule-1, VCAM-1, GAGs, Galactosaminoglycans, GalAGs, Dglucuronic acid, N-acetyl-D-galactosamine, Hyaluronan, Hyaluronan-Mediated Motility, RHAMM, Lymphatic Vessel Endothelial Receptor 1, LYVE-1, Hyaluronan Receptor for Endocytosis, HARE, Toll Like Receptors 4, TLR4, human aortic smooth muscle cells, AoSMCs, ADAMTS, TFPI-1, Tissue Factor Pathway Inhibitor-1
Abstract: Cardiovascular disease is the largest cause of death in Western societies and it primarily results from atherosclerosis of large and medium-sized vessels. Atherosclerosis leads to myocardial infarction, when it occurs in the coronary arteries, or stroke, when it occurs in the cerebral arteries. Pathological processes involved in macrovascular disease include the accumulation of lipids which are retained by extracellular matrix (ECM) molecules, especially by the chondroitin sulfate/dermatan sulfate (CS/DS) proteoglycans (CS/DSPGs), such as versican, biglycan and decorin. The sulfation pattern of CS is a key player in protein interactions causing atherosclerosis. Several studies have shown that lipoproteins bind CSPGs via their glycosaminoglycan chains. Galactosaminoglycans, such as CS and DS, bind low density lipoproteins (LDL), affecting the role of these molecules in the arterial wall. In this article, the role of CS and versican in atherosclerosis and hyaluronan in atherogenesis as well as the up to date known mechanisms that provoke this pathological condition are presented and discussed.
Export Options
About this article
Cite this article as:
E. Karangelis D., Kanakis I., P. Asimakopoulou A., Karousou E., Passi A., D. Theocharis A., Triposkiadi F., B. Tsilimingas N. and K. Karamanos Nikos, Glycosaminoglycans as Key Molecules in Atherosclerosis: The Role of Versican and Hyaluronan, Current Medicinal Chemistry 2010; 17 (33) . https://dx.doi.org/10.2174/092986710793205354
DOI https://dx.doi.org/10.2174/092986710793205354 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Amide-linked Ethanolamine Conjugate of Gemfibrozil as a Profound HDL Enhancer: Design, Synthesis, Pharmacological Screening and Docking Study
Current Drug Discovery Technologies Value of Carnitine Therapy in Kidney Dialysis Patients and Effects on Cardiac Function from Human and Animal Studies
Current Drug Targets Chemical Constituents and Biological Significance of the Genus Ilex (Aquifoliaceae)
The Natural Products Journal Insulin Secretion and Interleukin-1β Dependent Mechanisms in Human Diabetes Remission After Metabolic Surgery
Current Medicinal Chemistry Bortezomib – First Therapeutic Proteasome Inhibitor for Cancer Therapy: A Review of Patent Literature
Recent Patents on Anti-Cancer Drug Discovery Editorial [Hot Topic: The Medicinal Chemistry of New Agents to Treat Obesity (Guest Editor: Jinhwa Lee)]
Current Topics in Medicinal Chemistry Molecular Mechanisms of Inflammation. Anti-Inflammatory Benefits of Virgin Olive Oil and the Phenolic Compound Oleocanthal
Current Pharmaceutical Design Diagnosis of Cardiovascular Diseases Using Retinal Images Through Vessel Segmentation Graph
Current Medical Imaging The Role of Platelets in Bone Remodeling
Inflammation & Allergy - Drug Targets (Discontinued) Histamine-Dependent and -Independent Hypersensitivity Reactions to Contrast Media: The Impact of Antihistamines
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Clinical Efficacy and Effectiveness of Ursodeoxycholic Acid in Cholestatic Liver Diseases
Current Clinical Pharmacology Migraine and Coronary Artery Disease: An Open Study on the Genetic Polymorphism of the 5, 10 Methylenetetrahydrofolate (MTHFR) and Angiotensin I-Converting Enzyme (ACE) Genes
Central Nervous System Agents in Medicinal Chemistry Acute Passivation of Vulnerable Plaques with Wild-Type Apolipoprotein A-I in ApoE-Deficient Mice
Vascular Disease Prevention (Discontinued) Statin Therapy-Evidence Beyond Lipid Lowering Contributing to Plaque Stability
Current Medicinal Chemistry Podocytes as a Target of Insulin
Current Diabetes Reviews Ethical Considerations in Conducting Pediatric and Neonatal Research in Clinical Pharmacology
Current Pharmaceutical Design Lipid Messengers as Targets for Antiangiogenic Therapy
Current Pharmaceutical Design Should Adipokines be Considered in the Choice of the Treatment of Obesity-Related Health Problems?
Current Drug Targets Integrating Coronary Calcium into Risk Prediction: Current Approaches and Future Directions
Current Cardiology Reviews Neurobiological Mechanisms of Stress Resilience and Implications for the Aged Population
Current Neuropharmacology